{
    "id": 25862,
    "fullName": "PIK3CA D939G",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CA D939G lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). D939G has not been biochemically characterized, but is predicted to confer a gain of function on the Pik3ca protein as demonstrated by increased transformation ability in two different cell lines (PMID: 29533785).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 11238,
                    "pubMedId": 29533785,
                    "title": "Systematic Functional Annotation of Somatic Mutations in Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29533785"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5290,
        "geneSymbol": "PIK3CA",
        "terms": [
            "PIK3CA",
            "CLAPO",
            "CLOVE",
            "CWS5",
            "MCAP",
            "MCM",
            "MCMTC",
            "p110-alpha",
            "PI3K",
            "PI3K-alpha"
        ]
    },
    "variant": "D939G",
    "createDate": "01/05/2017",
    "updateDate": "07/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 171660,
        "transcript": "NM_006218",
        "gDna": "chr3:g.179230256A>G",
        "cDna": "c.2816A>G",
        "protein": "p.D939G",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9703,
            "approvalStatus": "Phase Ib/II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase Ib trial, an estrogen-receptor positive breast cancer patient harboring PIK3CA mutations, E78K, D939G, and E726K, demonstrated progressive disease when treated with a combination of Femara (letrozole) and Alpelisib (BYL719) (PMID: 27126994).",
            "molecularProfile": {
                "id": 26992,
                "profileName": "PIK3CA E78K PIK3CA E726K PIK3CA D939G"
            },
            "therapy": {
                "id": 1553,
                "therapyName": "Alpelisib + Letrozole",
                "synonyms": null
            },
            "indication": {
                "id": 60075,
                "name": "estrogen-receptor positive breast cancer",
                "source": "DOID"
            },
            "responseType": "no benefit",
            "references": [
                {
                    "id": 7484,
                    "pubMedId": 27126994,
                    "title": "A Phase Ib Study of Alpelisib (BYL719), a PI3K\u03b1-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27126994"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26990,
            "profileName": "PIK3CA D939G",
            "profileTreatmentApproaches": [
                {
                    "id": 18182,
                    "name": "Akt1 Inhibitor",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18175,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18179,
                    "name": "mTOR Inhibitor",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18177,
                    "name": "PI3K Inhibitor (Pan)",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18180,
                    "name": "PIK3CA inhibitor",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18178,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18181,
                    "name": "Akt Inhibitor (Pan)",
                    "profileName": "PIK3CA D939G"
                },
                {
                    "id": 18176,
                    "name": "Akt2 Inhibitor",
                    "profileName": "PIK3CA D939G"
                }
            ]
        },
        {
            "id": 26992,
            "profileName": "PIK3CA E78K PIK3CA E726K PIK3CA D939G",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171660,
            "transcript": "NM_006218",
            "gDna": "chr3:g.179230256A>G",
            "cDna": "c.2816A>G",
            "protein": "p.D939G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171661,
            "transcript": "XM_011512894",
            "gDna": "chr3:g.179230256A>G",
            "cDna": "c.2816A>G",
            "protein": "p.D939G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171659,
            "transcript": "XM_006713658",
            "gDna": "chr3:g.179230256A>G",
            "cDna": "c.2816A>G",
            "protein": "p.D939G",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}